Larimar Therapeutics (LRMR) Q4 2023 Earnings

14MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.3
-0.25
-0.2
-0.15

Details

Expected EPS
-0.248258
Actual EPS
-0.3
Surprise EPS
-0.05
Surprise Percent
+20.84%

Description

Larimar Therapeutics (LRMR) has reported earnings of -0.3 per share for Q4 2023.

0 Comments

Share your thoughts